TickerFactsScreenerDevelopers

Elicio Therapeutics, Inc. (ELTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$22.89M2021: -$52.64M2022: -$22.18M2023: -$32.69M2024: -$37.07M2025: -$36.95M-$36.95M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$36.95M+0.3%
2024-$37.07M-13.4%
2023-$32.69M-47.4%
2022-$22.18M+57.9%
2021-$52.64M-130.0%
2020-$22.89M—